ArticleEJHaem2022
Frontline polatuzumab vedotin for diffuse large B-cell lymphoma: A survey of clinician impressions.
Ajay Major et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleEJHaem2022
Ajay Major et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.